Eric Wang
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Molecular Biology top 2%
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- CRISPR and Genetic Engineering
- Genomics and Chromatin Dynamics
Papers in
-
- Acute Myeloid Leukemia Research 6
-
- Protein Degradation and Inhibitors 9
- RNA Research and Splicing 5
- Genomics and Chromatin Dynamics 4
- Histone Deacetylase Inhibitors Research 4
- RNA and protein synthesis mechanisms 4
- CRISPR and Genetic Engineering 3
- Epigenetics and DNA Methylation 3
- Co-authors
- Christopher R. Vakoc (9 shared papers)Junwei Shi (7 shared papers)Johannes A. Zuber (5 shared papers)Iannis Aifantis (7 shared papers)Joseph P. Milazzo (2 shared papers)Justin B. Kinney (2 shared papers)Zihua Wang (1 shared paper)Amy Rappaport (3 shared papers)
- Journals
- Cancer Discovery (3 papers)Molecular Cell (2 papers)Trends in cancer (2 papers)Nature (2 papers)Blood (2 papers)
- Partner nations
- United StatesAustriaItaly
In The Last Decade
Eric Wang
31 papers receiving 3.7k citations
Eric Wang's Hit Papers
Peers
Comparison fields: 5 of 106
- Hematology 894
- Molecular Biology 3.0k
- Aging 51
- Cancer Research 269
- Pediatrics, Perinatology and Child Health 312
Countries citing papers authored by Eric Wang
This map shows the geographic impact of Eric Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Wang more than expected).
Fields of papers citing papers by Eric Wang
This network shows the impact of papers produced by Eric Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Wang. The network helps show where Eric Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia Hit paper breakdown → | 2011 | 1464 |
| 2 | Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains Hit paper breakdown → | 2015 | 517 |
| 3 | Gestational age and maternal weight effects on fetal cell‐free DNA in maternal plasma Hit paper breakdown → | 2013 | 333 |
| 4 | 2019 | 234 | |
| 5 | 2009 | 155 | |
| 6 | 2020 | 151 | |
| 7 | 2015 | 112 | |
| 8 | 2013 | 105 | |
| 9 | 2012 | 96 | |
| 10 | 2008 | 64 | |
| 11 | 2023 | 61 | |
| 12 | 2015 | 51 | |
| 13 | 2017 | 51 | |
| 14 | 2021 | 51 | |
| 15 | 2015 | 49 | |
| 16 | 2013 | 47 | |
| 17 | 2004 | 42 | |
| 18 | 2015 | 42 | |
| 19 | 2021 | 39 | |
| 20 | 2022 | 32 |
About Eric Wang
Eric Wang is a scholar working on Hematology, Molecular Biology, Aging, Cancer Research and Oncology, having authored 33 papers that have together received 3.8k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (9 papers), Acute Myeloid Leukemia Research (6 papers), RNA Research and Splicing (5 papers), Genomics and Chromatin Dynamics (4 papers), Histone Deacetylase Inhibitors Research (4 papers), RNA and protein synthesis mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Hematology (894 citations), Molecular Biology (3.0k citations), Aging (51 citations), Cancer Research (269 citations) and Pediatrics, Perinatology and Child Health (312 citations). Eric Wang has collaborated with scholars based in United States, Austria and Italy. Frequent co-authors include Christopher R. Vakoc, Junwei Shi, Johannes A. Zuber, Iannis Aifantis, Joseph P. Milazzo, Justin B. Kinney, Zihua Wang, Amy Rappaport, Christopher Johns and Meredith J. Taylor. Their work appears in journals such as Cancer Discovery, Molecular Cell, Trends in cancer, Nature and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.